Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 14,100 shares, an increase of 12.8% from the August 15th total of 12,500 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average trading volume of 6,000 shares, the short-interest ratio is currently 2.4 days.
Anebulo Pharmaceuticals Stock Performance
NASDAQ:ANEB traded down $0.01 during mid-day trading on Monday, hitting $2.08. 2,300 shares of the company’s stock traded hands, compared to its average volume of 5,792. The company has a market cap of $53.94 million, a PE ratio of -5.62 and a beta of -1.01. The firm’s 50 day simple moving average is $2.09 and its 200 day simple moving average is $2.39. Anebulo Pharmaceuticals has a 1 year low of $1.62 and a 1 year high of $3.71.
Anebulo Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Anebulo Pharmaceuticals
- Compound Interest and Why It Matters When Investing
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How to Invest in Blue Chip Stocks
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Why Are These Companies Considered Blue Chips?
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Anebulo Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anebulo Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.